Healthcare Analytics Market: Growth, Size, Share, and Trends

Report Code HIT 2180
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), EndUser (Payer, Hospital, ACO, ASC, Govt, Clinic), & Region: Global Forecast to 2029

Overview

The global healthcare analytics market growth forecasted to transform from USD 44.83 billion in 2024 to USD 133.19 billion by 2029, driven by a CAGR of 24.3%. The growth of the market is primarily driven by increasing initiatives to boost EHR adoption, growing demand for data-driven decision-making, cost management, and operational efficiency, regulatory mandates aimed at improving value-based care, and rising venture capital investments in healthcare analytics startups. Furthermore, the integration of advanced technological solutions, such as generative AI, into healthcare analytics systems is accelerating market growth. Predictive analytics and machine learning algorithms, for example, can process up to 60 claims per hour, significantly enhancing payer efficiency and improving patient care.

Attractive Opportunities in the Healthcare Analytics Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to presence of a large and growing patient population, an increasing need for innovative therapies, the emergence of big data in healthcare, and increasing spending on HCIT infrastructure.

Technological advancements in analytical solutions, the rising need for improved data standardization, and the growing adoption of analytical solutions in clinical applications are key factors driving the market growth.

Utilization of analytics in real-world evidence & population health management and the growing adoption of cloud-based analytics solutions are factors expected to provide lucrative opportunities for market players.

The European healthcare analytics market is expected to grow due to increasing adoption of telehealth services and integration of big data into healthcare.

Issues associated with data integration and shortage of skilled personnel are expected to pose a challenge to the growth of this market.

Global Healthcare Analytics Market Dynamics

DRIVER: Government initiatives to increase EHR adoption

The EHR Incentive Programs under Medicare and Medicaid provide substantial financial support to eligible professionals (EPs), offering a significant incentive for the adoption and meaningful use of electronic health records (EHR). For instance, under the NY Medicaid EHR Incentive Program, EPs can receive up to USD 63,750 over six years of participation, with an initial payment of USD 21,250 in the first year and USD 8,500 for each of the following five years. Though capped at 2021, these incentives serve as a powerful driver for the widespread adoption of EHR systems.

Moreover, the global shift towards EHRs is transforming healthcare, with over 95% of US hospitals adopting these systems. Countries like Norway and South Korea report EHR adoption rates above 90%, while developing nations like India are seeing growth, currently at around 25%. Government initiatives in these countries are driving EHR adoption and investing in telemedicine to enhance access, especially in rural areas. As more providers implement EHRs, the demand for healthcare analytics solutions rises, allowing for better data interpretation and improved patient outcomes. This interconnected growth propels both EHR systems and analytics forward, leading to greater efficiency in healthcare delivery.

Restraints: Rising data breach concerns

Data breaches pose a significant restraint on the healthcare analytics market, primarily due to the elevated costs and heightened regulatory scrutiny associated with data security failures. With the average price of a healthcare data breach reaching USD 9.77 million in 2024, organizations are compelled to allocate substantial resources towards cybersecurity measures, diverting funds from innovation and analytics initiatives. This financial burden holds back investment in advanced analytical tools and technologies and fosters a culture of risk dislike, hindering the adoption of data-driven decision-making processes.

 

OPPORTUNITY: increasing adoption of cloud-based analytical solutions

The adoption of cloud-based analytical solutions is creating significant growth opportunities for healthcare analytics. With real-time updates capturing every data change, cloud platforms provide scalable storage, computing power, and advanced machine-learning capabilities, making them ideal for healthcare analytics. As demand for these solutions rises among healthcare organizations, several market players are developing cloud capabilities within their revenue cycle management systems. For instance, Fujitsu's recent launch of a new cloud-based platform facilitates the secure collection and utilization of health-related data, automating the conversion of medical records to comply with HL7 FHIR standards.

CHALLENGE: Dearth of skilled personnel

A shortage of in-house experts capable of translating large data volumes into actionable insights impedes the adoption of new technologies, potentially limiting the growth of the healthcare analytics market. The skill gap and inadequate data management capabilities limit the sector's growth. A report by the American Hospital Association indicates a potential shortfall of up to 3.2 million healthcare workers by 2026, worsened by high turnover rates—resignations among healthcare professionals surged from approximately 400,000 per month in 2020 to 600,000 by May 2023. Furthermore, McKinsey projects a shortfall of 200,000 to 450,000 registered nurses for direct patient care by 2025, underscoring the urgent need for skilled professionals.

Global Healthcare Analytics Market Ecosystem Analysis

The healthcare analytics market is highly competitive, with a large number of intermediaries involved. The market includes Healthcare Analytics vendors, ranging from large enterprises to niche players, that develop and provide innovative solutions deriving insights. These vendors navigate regulatory frameworks set by government bodies like the FDA, EMA, and Health Canada, ensuring compliance with standards and guidelines related to data security, interoperability, and patient privacy. Moreover, government bodies such as the Department of Health and Human Services (HHS) and the National Health Service (NHS) influence market dynamics through policy decisions, funding initiatives, and regulatory oversight. Meanwhile, end-users, comprising healthcare providers such as hospitals, clinics, payers demand for Healthcare Analytics solutions to streamline workflow efficiency, and enhance patient care delivery. This interconnected ecosystem relies on collaboration, innovation, and adherence to regulatory requirements to ensure the seamless integration and effective utilization of Healthcare Analytics solutions within the healthcare landscape.

 

By component type, the service segment accounted for the largest share of the healthcare analytics market in 2023.

By component type, the healthcare analytics market is segmented into services and solutions segment. The service segment accounted for the largest market share in 2023. This segment is further sub-segmented into managed services, which include analytical services, and consulting services, and professional services, which include training & implementation, maintenance, and support services. The segment is expected to witness the highest growth during the forecast period, primarily due to the rapid adoption of cloud services and the introduction of technologically advanced healthcare analytics software that requires regular upgrades and trained users.

Moreover, several players in the market are focusing on providing optimum services to gain an edge over their competitors and expand their existing customer base. Ketchum, Inc. introduced Vital Health, a predictive analytics-driven service for its existing healthcare customer base. This cloud-based analytics-as-a-service helps healthcare organizations to provide value-based care.

By application, clinical analytics accounted for the largest share of the Healthcare Analytics market in 2023.

Based on application, the Healthcare Analytics market is segmented into financial analytics, clinical analytics, operational & administrative analytics, and population health analytics. The clinical analytics segment dominates the application segment of the Healthcare Analytics market as these segments generate vast volumes of healthcare data sets such as patient information for diagnoses, treatments administered, prescribed medicines, procedures and lab tests conducted, and hospitalizations. This data is collected from various sources such as EHRs, disease registries, patient surveys, and information exchanges among care providers.

Moreover, under the current ICD-9 system, only 17,000 codes are available for identifying diagnoses and procedures in the US. This transition is required for everyone (providers, including physicians) covered by HIPAA. The implementation of ICD-10 has increased the amount of clinical data, and the management of this data requires advanced analytics. Owing to the increasing demand for personalized, data-driven care analytical solutions, the clinical analytics segment will remain at the forefront of Healthcare Analytics solutions to meet value-based patient care.

North America accounts the largest share of Healthcare Analytics market in 2023.

The Healthcare Analytics market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, North America accounted for the largest share of the market as the region is more focused on adopting value-based care delivery models. Healthcare providers and payers in the US are investing significantly in healthcare IT solutions, including analytical solutions. Moreover, increased regional spending on advanced technologies and healthcare expenditures positions this region at the forefront of adopting innovative solutions.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION

Recent Developments of Healthcare Analytics Market

  • In April 2023, Thermo Fisher Scientific Inc. launched Neon NxT Electroporation system used for the enhancement of genome editing. The system is suitable for transfection of challenging cell lines.
  • In February 2022, Polyplus acquired e-Zyvec, a provider of DNA design and production services for tailor-made DNA vectors. The acquisition aims to expand the portfolio in DNA vector engineering.

Key Market Players

KEY PLAYERS IN THE HEALTHCARE ANALYTICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Healthcare Analytics Market?

Scope of the Report

Report Metric Details
Market size for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Million/Billion (USD)
Segments covered Component, Type, Application, and End user
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East Africa.

Key Questions Addressed by the Report

The global healthcare analytics market is projected to grow from USD 44.83 billion in 2024 to USD 133.19 billion by 2029, demonstrating a robust CAGR of 24.3%
Key players in the global healthcare analytics market include Merative (US), Veradigm (US), EXL (US), HealthCatalyst (US), and Ketchum, Inc. (US).
The primary drivers of the healthcare analytics market include government initiatives to increase EHR adoption, rising demand for data-driven decision-making, and the adoption of cloud-based solutions in healthcare analytics.
North America accounts for the largest share of the healthcare analytics market, driven by the focus on adopting value-based care delivery models and significant investments in healthcare IT solutions.
Data breaches present a major challenge for the healthcare analytics market due to the rising costs and regulatory scrutiny. The average price of a healthcare data breach is USD 9.77 million in 2024, which hinders investments in advanced analytics solutions.
Healthcare analytics is mainly applied in clinical analytics, financial analytics, operational and administrative analytics, and population health analytics, with clinical analytics holding the largest share.
The healthcare analytics market faces challenges such as a dearth of skilled personnel capable of analyzing large data volumes and a shortage of healthcare workers, which limits the adoption of new technologies and analytics solutions.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Healthcare Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
38
RESEARCH METHODOLOGY
42
EXECUTIVE SUMMARY
57
PREMIUM INSIGHTS
61
MARKET OVERVIEW
65
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Favorable government initiatives for electronic health record adoption
    - Growing venture capital investments in startups
    - Need to reduce healthcare costs
    - Increasing focus on real-world evidence
    - Rise of telemedicine and remote patient monitoring
    - Growing focus on regulatory compliance
    RESTRAINTS
    - High cost of analytics solutions
    - Growing concerns about data breach
    OPPORTUNITIES
    - Increasing focus on value-based medicines
    - Growing use of analytics in healthcare
    - Rising number of patient registries
    - Emergence of social media and digital health technologies
    CHALLENGES
    - Concerns regarding inaccurate and inconsistent data
    - Reluctance to adopt healthcare analytics solutions in developing countries
    - Lack of maintenance of medical records
    - Shortage of skilled personnel
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 INDUSTRY TRENDS
    INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS
    SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
    GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Big data analytics
    - Artificial intelligence and machine learning
    - Business intelligence tools
    ADJACENT TECHNOLOGIES
    - Cloud computing
    - Internet of things
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    GOVERNMENT REGULATIONS
    - US
    - Europe
    - China
    - Japan
    - India
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
    AVERAGE SELLING PRICE, BY REGION
  • 5.10 PORTER’S FIVE FORCES ANALYSIS
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 END-USER ANALYSIS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.14 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.15 CASE STUDY ANALYSIS
  • 5.16 BUSINESS MODEL ANALYSIS
  • 5.17 INVESTMENT AND FUNDING SCENARIO
  • 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
    KEY USE CASES
    CASE STUDY ON AI/GEN AI
    ADJACENT MARKET ECOSYSTEM
    - Life science analytics market
    - Healthcare IT market
    - Healthcare fraud analytics market
    USER READINESS AND IMPACT ASSESSMENT
    - User readiness
    - Impact assessment
HEALTHCARE ANALYTICS MARKET, BY COMPONENT
115
  • 6.1 INTRODUCTION
  • 6.2 SERVICES
    MANAGED SERVICES
    - Analytical services
    - Consulting services
    PROFESSIONAL SERVICES
    - Training & implementation services
    - Maintenance & support services
  • 6.3 SOFTWARE
    ON-PREMISE SOFTWARE
    - Provision of multi-vendor architecture and security benefits to drive market
    CLOUD-BASED SOFTWARE
    - Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption
HEALTHCARE ANALYTICS MARKET, BY TYPE
132
  • 7.1 INTRODUCTION
  • 7.2 DESCRIPTIVE ANALYTICS
    INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
  • 7.3 PREDICTIVE ANALYTICS
    ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH
  • 7.4 PRESCRIPTIVE ANALYTICS
    NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH
  • 7.5 DIAGNOSTIC ANALYTICS
    RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH
HEALTHCARE ANALYTICS MARKET, BY APPLICATION
141
  • 8.1 INTRODUCTION
  • 8.2 FINANCIAL ANALYTICS
    CLAIMS PROCESSING
    - Increasing shift from paper-based claims processing to electronic mode to augment growth
    REVENUE CYCLE MANAGEMENT
    - Growing focus on financial forecasting and budgeting process to boost market
    PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
    - Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market
    RISK ADJUSTMENT & ASSESSMENT
    - Rise in special enrollment periods and new subsidies to accelerate growth
  • 8.3 CLINICAL ANALYTICS
    QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
    - Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market
    CLINICAL DECISION SUPPORT
    - Need to reduce medical errors and expedite diagnosis to boost market
    REPORTING & COMPLIANCE
    - Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth
    COMPARATIVE ANALYTICS/EFFECTIVENESS
    - Growing adoption of electronic health records to fuel market
    PRECISION HEALTH/REAL-WORLD EVIDENCE
    - Strong government support for personalized medicine to sustain growth
    MEDICAL IMAGING ANALYTICS
    - Ability to provide real-time insights and diagnosis of genetic disorders to aid growth
  • 8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
    SUPPLY CHAIN ANALYTICS
    - Growing need to reduce healthcare costs and implement better inventory management practices to fuel market
    WORKFORCE ANALYTICS
    - Need for effective recruitment to favor growth
    STRATEGIC ANALYTICS
    - Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market
  • 8.5 POPULATION HEALTH ANALYTICS
    RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH
HEALTHCARE ANALYTICS MARKET, BY END USER
169
  • 9.1 INTRODUCTION
  • 9.2 PAYERS
    PRIVATE INSURANCE COMPANIES
    - Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth
    GOVERNMENT AGENCIES
    - Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market
  • 9.3 PROVIDERS
    HOSPITALS & CLINICS
    - Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market
    POST-ACUTE CARE ORGANIZATIONS
    - Increasing use of analytics solutions to review and study patient data to drive market
    AMBULATORY SURGERY CENTERS
    - Need to control healthcare costs to support market
    OTHER PROVIDERS
  • 9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
    MANUFACTURERS
    - Growing adoption of digital technologies to drive market
    DISTRIBUTORS & WHOLESALERS
    - Need for improved supply chain operations, inventory management, and service delivery to boost market
    RETAILERS
    - Rising integration of healthcare analytics into retail operations to stimulate growth
HEALTHCARE ANALYTICS MARKET, BY REGION
187
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - High adoption of electronic health records to drive market
    CANADA
    - Need for managing patient volumes, clinical data, and healthcare costs to favor market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Government initiatives to increase use of analytics in healthcare
    UK
    - Availability of venture capital investments to drive market
    FRANCE
    - Strong financial support for digital health to augment market
    ITALY
    - Growing number of drug approvals to drive uptake of analytics solutions
    SPAIN
    - Growing adoption of personalized medicine to drive market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Rising geriatric population to drive demand for effective patient management solutions
    CHINA
    - Favorable reforms and growing number of electronic health records to aid growth
    INDIA
    - Favorable government initiatives to fuel market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growing adoption of digital solutions in healthcare to boost market
    MEXICO
    - Growing prominence of startups and rising R&D activity to propel market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Rising investments, advancements, and developing healthcare infrastructure to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
317
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024
  • 11.3 REVENUE ANALYSIS, 2019–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/SOFTWARE COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Component footprint
    - Application footprint
    - End-user footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES
    DEALS
    EXPANSIONS
COMPANY PROFILES
338
  • 12.1 KEY PLAYERS
    MERATIVE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    SAS INSTITUTE INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    OPTUM, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ORACLE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    VERADIGM LLC
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    EXLSERVICE HOLDINGS, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    CITIUSTECH INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    HEALTH CATALYST
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    CVS HEALTH
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    INOVALON
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    MCKESSON CORPORATION
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    MEDEANALYTICS, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    COTIVITI, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    APIXIO, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    ENLITIC
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    KOMODO HEALTH, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    HEALTHEC, LLC
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    IQVIA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    WIPRO
    - Business overview
    - Products/Solutions/Services offered
  • 12.2 OTHER PLAYERS
    ARCADIA SOLUTIONS, LLC.
    EVIDATION HEALTH, INC.
    HEALTHCORUM
    AETION, INC.
    TREDENCE.INC.
    SISENSE LTD.
APPENDIX
402
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 HEALTHCARE ANALYTICS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH ASSUMPTIONS
  • TABLE 3 HEALTHCARE ANALYTICS MARKET: RISK ASSESSMENT
  • TABLE 4 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023
  • TABLE 5 HEALTHCARE ANALYTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 6 NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 7 EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 8 ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 10 LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
  • TABLE 17 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION
  • TABLE 18 HEALTHCARE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 19 HEALTHCARE ANALYTICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2020–2023
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USER (%)
  • TABLE 21 KEY BUYING CRITERIA FOR END USER
  • TABLE 22 UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET
  • TABLE 23 END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET
  • TABLE 24 HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 25 ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS
  • TABLE 26 USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT
  • TABLE 27 ENHANCED CLINICAL DECISION-MAKING PROCESS WITH DATA OPERATING SYSTEM PLATFORM
  • TABLE 28 ENHANCED PATIENT OUTCOMES WITH AI-DRIVEN PREDICTIVE ANALYTICS
  • TABLE 29 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 30 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 31 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 33 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 HEALTHCARE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 HEALTHCARE ANALYTICS MARKET FOR CONSULTING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 37 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 HEALTHCARE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 HEALTHCARE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 41 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 45 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 APPLICATIONS OF PREDICTIVE ANALYTICS
  • TABLE 47 COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS
  • TABLE 48 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS
  • TABLE 50 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 53 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
  • TABLE 54 FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 55 FINANCIAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
  • TABLE 57 FINANCIAL ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
  • TABLE 59 FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
  • TABLE 61 FINANCIAL ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
  • TABLE 63 FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
  • TABLE 65 CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 66 CLINICAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
  • TABLE 68 CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
  • TABLE 70 CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
  • TABLE 72 CLINICAL ANALYTICS MARKET FOR REPORTING & COMPLIANCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
  • TABLE 74 CLINICAL ANALYTICS MARKET FOR COMPARATIVE ANALYTICS/EFFECTIVENESS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD EVIDENCE SOLUTIONS
  • TABLE 76 CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH/REAL-WORLD EVIDENCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
  • TABLE 78 CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
  • TABLE 80 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 81 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
  • TABLE 83 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 84 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
  • TABLE 85 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 86 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
  • TABLE 88 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 89 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 90 COMMERCIALLY AVAILABLE SOLUTIONS FOR HEALTHCARE PAYERS
  • TABLE 91 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 94 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 95 COMMERCIALLY AVAILABLE ANALYTICS SOLUTIONS FOR HEALTHCARE PROVIDERS
  • TABLE 96 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 98 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR HOSPITALS & CLINICS
  • TABLE 99 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 100 HEALTHCARE ANALYTICS MARKET FOR POST-ACUTE CARE ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 101 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR AMBULATORY SURGERY CENTERS
  • TABLE 102 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 103 COMMERCIALLY AVAILABLE SOLUTIONS FOR ACCOUNTABLE CARE ORGANIZATIONS
  • TABLE 104 HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 105 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 107 HEALTHCARE ANALYTICS MARKET FOR MANUFACTURERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 108 HEALTHCARE ANALYTICS MARKET FOR DISTRIBUTORS & WHOLESALERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 109 HEALTHCARE ANALYTICS MARKET FOR RETAILERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 110 HEALTHCARE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 127 US: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 US: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 US: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 US: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 133 US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 US: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 137 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 US: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 141 CANADA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 CANADA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 CANADA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 147 CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 151 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 CANADA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 156 EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 162 EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 166 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 170 GERMANY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 GERMANY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 GERMANY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 176 GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 180 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 184 UK: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 UK: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 UK: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 UK: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 190 UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 194 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 UK: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 198 FRANCE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 FRANCE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 FRANCE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 204 FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 208 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 212 ITALY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 ITALY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 ITALY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 ITALY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 218 ITALY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 ITALY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 ITALY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 222 ITALY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 ITALY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 ITALY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 226 SPAIN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 SPAIN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 SPAIN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 232 SPAIN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 SPAIN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 SPAIN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 236 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 237 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 240 REST OF EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 REST OF EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 246 REST OF EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 REST OF EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 REST OF EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 250 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 255 ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 265 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 269 JAPAN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 JAPAN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 JAPAN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 275 JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 279 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 283 CHINA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 CHINA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 CHINA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 289 CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 293 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 CHINA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 297 INDIA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 INDIA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 INDIA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 303 INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 305 INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 307 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 INDIA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 311 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 313 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 315 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 316 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 317 REST OF ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 REST OF ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 REST OF ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 321 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 325 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 326 LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 332 LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 336 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 340 BRAZIL: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 343 BRAZIL: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 346 BRAZIL: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 BRAZIL: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 BRAZIL: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 350 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 351 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 354 MEXICO: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 MEXICO: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 MEXICO: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 360 MEXICO: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 361 MEXICO: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 MEXICO: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 363 MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 364 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 366 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 368 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 374 REST OF LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 375 REST OF LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 REST OF LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 378 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 382 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 383 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 384 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 389 MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 390 MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 391 MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 392 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 393 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 395 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 396 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 397 GCC COUNTRIES: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 403 GCC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 GCC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 405 GCC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 406 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 407 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 411 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 412 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 416 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 417 REST OF MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 418 REST OF MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 REST OF MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 421 REST OF MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 423 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 424 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET, 2021–2024
  • TABLE 425 HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION
  • TABLE 426 HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT
  • TABLE 427 HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT
  • TABLE 428 HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT
  • TABLE 429 HEALTHCARE ANALYTICS MARKET: END-USER FOOTPRINT
  • TABLE 430 HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES
  • TABLE 431 HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 432 HEALTHCARE ANALYTICS MARKET: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 433 HEALTHCARE ANALYTICS MARKET: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 434 HEALTHCARE ANALYTICS MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 435 MERATIVE: COMPANY OVERVIEW
  • TABLE 436 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 437 MERATIVE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 438 MERATIVE: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 439 SAS INSTITUTE INC.: COMPANY OVERVIEW
  • TABLE 440 SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 441 SAS INSTITUTE INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 442 OPTUM, INC.: COMPANY OVERVIEW
  • TABLE 443 OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 444 OPTUM, INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 445 ORACLE: COMPANY OVERVIEW
  • TABLE 446 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 447 ORACLE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 448 ORACLE: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 449 ORACLE: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 450 VERADIGM LLC: COMPANY OVERVIEW
  • TABLE 451 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 452 VERADIGM LLC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 453 VERADIGM LLC: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 454 VERADIGM LLC: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 455 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 456 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 457 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 458 EXLSERVICE HOLDINGS, INC.: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 459 EXLSERVICE HOLDINGS, INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 460 EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 461 CITIUSTECH INC.: COMPANY OVERVIEW
  • TABLE 462 CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 463 CITIUSTECH INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 464 CITIUSTECH INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 465 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 466 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 467 HEALTH CATALYST: COMPANY OVERVIEW
  • TABLE 468 HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 469 HEALTH CATALYST: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 470 HEALTH CATALYST: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 471 CVS HEALTH: COMPANY OVERVIEW
  • TABLE 472 CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 473 CVS HEALTH: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 474 INOVALON: COMPANY OVERVIEW
  • TABLE 475 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 476 INOVALON: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 477 INOVALON: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 478 INOVALON: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 479 INOVALON: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 480 MCKESSON CORPORATION: COMPANY OVERVIEW
  • TABLE 481 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 482 MCKESSON CORPORATION: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 483 MEDEANALYTICS, INC.: COMPANY OVERVIEW
  • TABLE 484 MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 485 MEDEANALYTICS, INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 486 MEDEANALYTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 487 COTIVITI, INC.: COMPANY OVERVIEW
  • TABLE 488 COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 489 COTIVITI, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 490 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 491 APIXIO, INC.: COMPANY OVERVIEW
  • TABLE 492 APIXIO, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 493 APIXIO, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 494 APIXIO, INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 495 ENLITIC: COMPANY OVERVIEW
  • TABLE 496 ENLITIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 497 ENLITIC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 498 ENLITIC: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 499 KOMODO HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 500 KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 501 KOMODO HEALTH, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024
  • TABLE 502 KOMODO HEALTH, INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 503 HEALTHEC, LLC: COMPANY OVERVIEW
  • TABLE 504 HEALTHEC, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 505 HEALTHEC, LLC: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 506 IQVIA: COMPANY OVERVIEW
  • TABLE 507 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 508 IQVIA: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 509 WIPRO: COMPANY OVERVIEW
  • TABLE 510 WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 511 ARCADIA SOLUTIONS, LLC.: COMPANY OVERVIEW
  • TABLE 512 EVIDATION HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 513 HEALTHCORUM: COMPANY OVERVIEW
  • TABLE 514 AETION, INC.: COMPANY OVERVIEW
  • TABLE 515 TREDENCE.INC.: COMPANY OVERVIEW
  • TABLE 516 SISENSE LTD.: COMPANY OVERVIEW
LIST OF FIGURE
 
  • FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF OPTUM, INC. (2023)
  • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2029
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 12 HEALTHCARE ANALYTICS MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET
  • FIGURE 18 GOVERNMENT INITIATIVES TO INCREASE ELECTRONIC HEALTH RECORD ADOPTION AND INCREASED PRESSURE TO CURB HEALTHCARE COSTS TO PROPEL MARKET
  • FIGURE 19 NORTH AMERICA HELD LARGEST SHARE OF HEALTHCARE ANALYTICS MARKET IN 2023
  • FIGURE 20 INDIA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 21 NORTH AMERICA DOMINATED MARKET IN 2023
  • FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 HEALTH EXPENDITURE AS A SHARE OF GDP, 2022 (OR NEAREST YEAR)
  • FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009–2023
  • FIGURE 26 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009–2023
  • FIGURE 27 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN HEALTHCARE ANALYTICS MARKET
  • FIGURE 28 HEALTHCARE ANALYTICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 HEALTHCARE ANALYTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 HEALTHCARE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 31 HEALTHCARE ANALYTICS MARKET: PATENT ANALYSIS, JANUARY 2015–SEPTEMBER 2024
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USER
  • FIGURE 33 KEY BUYING CRITERIA FOR END USER
  • FIGURE 35 MARKET POTENTIAL OF AI/GEN AI IN ENHANCING HEALTHCARE ANALYTICS ACROSS INDUSTRIES
  • FIGURE 36 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 37 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET SNAPSHOT
  • FIGURE 39 HEALTHCARE ANALYTICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023
  • FIGURE 40 HEALTHCARE ANALYTICS MARKET: MARKET SHARE ANALYSIS, 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF HEALTHCARE ANALYTICS VENDORS, 2024
  • FIGURE 43 HEALTHCARE ANALYTICS MARKET: BRAND/SOFTWARE COMPARISON
  • FIGURE 44 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 HEALTHCARE ANALYTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 46 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 OPTUM, INC: COMPANY SNAPSHOT (2023)
  • FIGURE 48 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 49 VERADIGM LLC: COMPANY SNAPSHOT (2021)
  • FIGURE 50 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 51 HEALTH CATALYST: COMPANY SNAPSHOT (2023)
  • FIGURE 52 CVS HEALTH: COMPANY SNAPSHOT (2021)
  • FIGURE 53 MCKESSON CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 54 IQVIA: COMPANY SNAPSHOT (2023)
  • FIGURE 55 WIPRO: COMPANY SNAPSHOT (2023)

The study involved five major activities to estimate the current size of the Healthcare Analytics market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of Healthcare Analytics Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global Healthcare Analytics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare analytics market. These methods were also used extensively to estimate the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following:

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Healthcare Analytics Market.

Market Definition

Healthcare analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, diagnostics, and other emerging applied analytical models. These tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for the improved clinical, financial, and operational performance of healthcare organizations.

Stakeholders

  • Stakeholders
  • Healthcare IT firms
  • Healthcare Analytics Vendors
  • Health Insurance Exchanges
  • Healthcare Payers
  • Healthcare Providers
  • Venture Capitalists
  • Research and Consulting Firms
  • Accountable Care Organizations (ACOs)

Report Objectives

  • To define, describe, and forecast the global Healthcare Analytics market based on component, type, application, end-user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall Healthcare Analytics  market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile the key players of the Healthcare Analytics market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, agreements, sales contracts, and alliances in the Healthcare Analytics market during the forecast period.

Previous Versions of this Report

Carbon Fiber Tape Market by Form (Prepreg Tape, Dry Tape), Resin (Epoxy, Thermoplastic, Polyamide), Manufacturing Process (Hot Melt, Solvent Dip), End-use Industry (Aerospace, Marine, Pipe & Tank, Sporting Goods), and Region - Global Forecast to 2027

Report Code HIT 2180
Published in Dec, 2022, By MarketsandMarkets™

Healthcare Analytics Market by Type (Descriptive, Prescriptive, Cognitive), Application (Financial, Operational, RCM, Fraud, Clinical), Component (Services, Hardware), Deployment (On-premise, Cloud), End-user (Providers, Payer) - Global Forecast to 2026

Report Code HIT 2180
Published in Sep, 2021, By MarketsandMarkets™

Healthcare Analytics Market by Type (Predictive, Prescriptive, Cognitive) Application (Clinical, RCM, Claim, Fraud, Waste, Supply Chain, PHM) Component (Service, Software) Delivery (On-demand, Cloud) End User (Payer, Hospital) - Global Forecast to 2024

Report Code HIT 2180
Published in Jan, 2019, By MarketsandMarkets™

Healthcare Analytics/Medical Analytics Market by Type (predictive, prescriptive) Application (Clinical, RCM, Claim, Fraud, Waste, Supply Chain, PHM) Component (Service, Software) Delivery (On demand, Cloud) End User (Payer, Hospital, ACO) - Global Forecast to 2022

Report Code HIT 2180
Published in Nov, 2017, By MarketsandMarkets™

Healthcare Analytics/ Medical Analytics Market by Application (Clinical, RCM, Claim, Fraud, Supply Chain, HR, PHM), Type (Prescriptive), Component (Service, Software), Delivery (On-premise, Cloud), End User (Hospital, Payer, ACO, TPA) - Forecasts to 2021

Report Code HIT 2180
Published in Nov, 2016, By MarketsandMarkets™

Healthcare Analytics/Medical Analytics Market by Application (Clinical, PHM, Financial (RCM, Claim, Fraud), Supply Chain, HR)), Type (Predictive), Delivery model (On-premise, Cloud), End-user (Payer, Hospital, Ambulatory, ACO) - Global Forecast to 2020

Report Code HIT 2180
Published in Jul, 2015, By MarketsandMarkets™

Healthcare Analytics/Medical Analytics Market by Applications, Types & End-User - 2020 | MarketsandMarkets

Report Code HIT 2180
Published in Dec, 2013, By MarketsandMarkets™

Healthcare Analytics/Medical Analytics Market by Application (Clinical, Financial, & Operational), Type (Predictive, & Prescriptive), End-user (Payer, Provider, HIE, ACO), Delivery Mode (On-premise, Web, & Cloud) - Trends & Global Forecasts to 2020

Report Code HIT 2180
Published in Dec, 2013, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Healthcare Analytics Market

User

Jul, 2022

Which major players have been included in the healthcare analytics market study? .

Noah

Mar, 2022

Can you share the detailed information on technological advancements in the Healthcare Analytics Market?.

Jeremy

Mar, 2022

In what way COVID19 is Impacting the global growth of the Healthcare Analytics Market?.

Christian

Mar, 2022

Can you enlighten us about the key players operating in the global Healthcare Analytics Market?.

DMCA.com Protection Status